Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.4959
Abstract: This cohort study examines the association between tumor-infiltrating lymphocyte classification and disease progression among patients with metastatic primary cutaneous melanoma receiving checkpoint inhibitor therapy. read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.26337
Abstract: Key Points Question Are tumor-infiltrating lymphocytes (TILs) an independent prognostic factor for overall survival among patients with primary cutaneous melanoma? Findings This cohort study identified clinical and histopathologic characteristics of 14 436 patients with cutaneous melanoma… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Advanced healthcare materials"
DOI: 10.1002/adhm.202300420
Abstract: Mast cells (MCs), powerful immune cells that heavily infiltrate cancer cells, play a crucial role in tumor formation. Activated MCs can release histamine and a family of proteases through degranulation effects, concurrently achieving endothelial junction… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2580
Abstract: The aim of this study was to investigate the tumor microenvironment immune types (TMIT) based on tumor cell programmed cell death ligand 1 (PD‐L1) expression and tumor‐infiltrating lymphocytes (TILs) distribution and whether distinct TMIT subtypes… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.4050
Abstract: The goal was to compare the 5‐year DFS and 5‐year OS in patients with early‐stage human epidermal growth factor receptor 2 breast cancer (HER2+ BC) and triple‐negative breast cancer (TNBC) in relation to the amount… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5590
Abstract: At present, there is still a lack of reliable biomarkers for ovarian cancer (OC) to guide prognosis prediction and accurately evaluate the dominant population of immunotherapy. In recent years, the relationship between peripheral blood markers… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.70179
Abstract: Tumor cells (TC) participate in tumor progression by altering the immune responses in the tumor microenvironment. However, the clinical relevance and prognostic effect of PD‐L1 expression and tumor‐infiltrating lymphocytes (TILs) in esophageal squamous cell carcinoma… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34013
Abstract: The significance of tumor‐infiltrating lymphocytes (TILs) in melanoma is debated. This article presents a multicenter, retrospective study assessing the predictive and prognostic value of TILs. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Cytopathology"
DOI: 10.1002/cncy.22551
Abstract: Tumor‐infiltrating lymphocytes (TILs) are associated with various clinicopathological features. Using cytologic specimens for assessing TILs remains to be established. This retrospective study aimed to establish a practical method to assess TILs in cytologic samples. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31213
Abstract: Tumor cells frequently overexpress heat shock protein 70 (Hsp70) and present it on their cell surface, where it can be recognized by pre‐activated NK cells. In our retrospective study the expression of Hsp70 was determined… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "International journal of cancer"
DOI: 10.1002/ijc.70166
Abstract: Tumor‐infiltrating B cells (TIBs) exhibit dual roles in the tumor microenvironment (TME) of solid tumors. While they can enhance anti‐tumor immunity through antibody production and immune activation, certain subsets—such as regulatory B cells (Bregs) and… read more here.